What the Research Says
Vitamin E research has shown a complex risk-benefit profile. The landmark 2005 meta-analysis by Miller et al. (Annals of Internal Medicine) analyzed 19 trials (n=135,967) and found that high-dose vitamin E (≥400 IU/day) was associated with increased all-cause mortality. The SELECT trial (2011, JAMA, n=35,533) found that vitamin E at 400 IU/day increased prostate cancer risk by 17% in healthy men. However, Meydani et al. (1997, JAMA) demonstrated immune benefits at 200 mg/day in the elderly, and Dysken et al. (2014, JAMA) showed vitamin E at 2,000 IU/day delayed functional decline in Alzheimer's disease. Current consensus favors obtaining vitamin E from food rather than supplements for most people.
